Stryker Corporation (SYK) Earnings Call Transcripts

Stryker Corporation's Latest Earnings Call - September 8, 2026

In the third quarter of 2026, Stryker Corporation (SYK:US) reported ongoing challenges in its peripheral vascular and joint replacement businesses, which could impact investor sentiment. The company maintained its organic growth guidance of 8.3% to 9.3%, with a midpoint of 8.8%, despite supply chain issues affecting the peripheral vascular segment. Revenue growth was hindered by a 70-80 basis point impact from these challenges, leading to cautious expectations for the remainder of the fiscal year.

Reported metrics

Guidance from management

Stryker maintained its organic growth guidance of 8.3% to 9.3% for the fiscal year, with a cautious outlook due to ongoing supply chain issues, particularly in the peripheral vascular and joint replacement segments.

What management said

We're not saying anything yet on Q4. Certainly, as we get into our Q3 earnings call, we'll have a better sense of how that's doing. I mean it's a really dynamic time in terms of trying to understand how that's happening because there's a little bit of fits and starts as you go through it. I would just say for now, we do anticipate the third quarter to be very similar to second quarter in terms of the impact of PV on ...

Yes, we're not -- procedures are still being done. So we're working to prioritize, let's call it, our top 100 right now as we try to make sure that they have enough inventory to continue to do procedures moving forward. So -- but it's not 100% where it needs to be. So inventory levels aren't 100% where they need to be all the time to do that. So we're still working on trying to make sure that we're supplying enough i...

What analysts pressed on

Analysts expressed concerns about the prolonged supply chain issues affecting the peripheral vascular business and the slower-than-expected recovery in joint replacements. There is also worry about the potential impact of external economic factors on consumer behavior and procedure demand.

Main topics on the call

• Peripheral Vascular Challenges — Stryker's peripheral vascular business continues to face supply chain issues, which have persisted longer than anticipated. CFO Preston Wells noted, "the peripheral vascular isn't quite seeing that same recovery that we ...
• Joint Replacement Market Slowdown — The joint replacement business, particularly in hips, has not recovered as expected, with management citing seasonal factors and external pressures. Wells stated, "we expected to see some better recovery... but what we a...
• Strong Demand for Capital Products — Despite challenges in certain segments, demand for capital products remains robust, with a strong order book. Wells mentioned, "we see really strong capital demand for our capital products," indicating a positive outlook...
• Cyber Event Impact — The cyber incident earlier in the year continues to affect operations, but management believes that the capital businesses are recovering as expected. Wells stated, "the capital businesses themselves remain really health...

Read the full Stryker Corporation transcript (September 8, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 54 Stryker Corporation earnings call transcripts on record, spanning January 28, 2020 to September 8, 2026. Based on this history, Stryker Corporation reports quarterly. The most recent call on file is dated September 8, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

SYK

Exchange

NYSE

Country

US

Sector

Health Care

Industry

Health Care Equipment and Supplies

Calls on record

54

First call

January 28, 2020

Most recent

September 8, 2026

Reporting cadence

quarterly